When a blockage forms in the brain's blood vessels, doctors must decide quickly whether to intervene. This real-world study looked at 174 patients who had these blockages and underwent endovascular treatment, a procedure to clear the vessel. The team compared those treated early with those treated later to see if timing mattered for safety.
The results showed no clear advantage for one group over the other. Patients treated early had an 11.3% risk of stroke or death within 30 days, while those treated later had an 8.3% risk. This difference was not statistically significant, meaning the data did not prove that early treatment was safer or more effective in this specific setting.
At 90 days, the risk of unfavorable outcomes was 18.9% for the early group and 10.7% for the delayed group. Again, this difference did not reach statistical significance. The study also found that factors like higher initial stroke severity and specific blood chemistry levels influenced the decision on when to treat, rather than the timing itself.
It is important to remember this study looked at patients in a single center, which means these results reflect one specific practice environment. While the findings suggest timing may not be a deciding factor for survival in this group, every patient is different, and doctors must weigh individual risks and benefits carefully.